Cost-effectiveness of hypothetical miRNA biomarker testing for post-treatment surveillance of HPV-negative OPSCC

Rema Shah,Sidharth Tyagi,Dimitra Vageli,Benjamin Judson

Oral Oncology Reports（2023）

引用 0|浏览8

暂无评分

摘要

•An miRNA biomarker strategy is a cost-effective surveillance option for HPV- oropharyngeal cancer.•A cost-effective miRNA test should cost less than $451.80•Currently used surveillance practices cost between $4000- and $16,000 more than a hypothetical miRNA test.

查看译文

关键词

miRNA,Biomarker,Oropharyngeal squamous cell carcinoma,Cost-effectiveness,Surveillance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要